CRISPR Therapeutics
CRSP
#3305
Rank
โ‚ฌ2.92 B
Marketcap
33,86ย โ‚ฌ
Share price
-1.76%
Change (1 day)
-35.75%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2023 (TTM): -5,11ย โ‚ฌ

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -4,66ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -7,35ย โ‚ฌ a decrease over its 2021 EPS that were of 4,38ย โ‚ฌ.

EPS history for CRISPR Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-5,11ย โ‚ฌ-30.51%
2022-7,35ย โ‚ฌ-267.74%
20214,38ย โ‚ฌ-194.33%
2020-4,65ย โ‚ฌ-576.58%
20190,98ย โ‚ฌ-132.36%
2018-3,01ย โ‚ฌ100.58%
2017-1,50ย โ‚ฌ159.42%
2016-0,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-1,92ย โ‚ฌ-58.87%๐Ÿ‡บ๐Ÿ‡ธ USA